Pfizer Inc. Boosts Quarterly Dividend to $0.42, Marking Its Commitment to Investors Amid Steady Growth | CSIMarket News

Pfizer Inc. Boosts Quarterly Dividend to $0.42, Marking Its Commitment to Investors Amid Steady Growth

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

NEW YORK - Pfizer Inc. (NYSE: PFE) continues to prioritize its shareholders as it declares an increase in the quarterly cash dividend on the company s common stock to $0.42 for the first quarter of 2024. This marks the 341st consecutive quarterly dividend paid by Pfizer and reflects the company s dedication to deliver value to its investors. The first-quarter 2024 dividend will be payable on March 1, 2024, to holders of the Common Stock of record at the close of business on January 26, 2024.This recent announcement by Pfizer comes on the heels of its previous press release on October 4, 2023, in which the company announced the fourth-quarter 2023 dividend. Titled A Steady Path Amid Industry Competition and Growth Potential, this news further highlighted Pfizer s commitment to maintaining a reliable dividend payout while navigating a competitive healthcare sector.Pfizer s decision to increase its quarterly dividend for the first quarter of 2024 showcases the company s confidence in its financial position and future growth prospects. The raise from the previous dividend clearly demonstrates management s belief in sustaining long-term shareholder value.As of the writing of this article, Pfizer Inc s 12 Months dividend payout ratio has sequentially increased to 87.85 in the third quarter of 2023. This indicates the company s commitment to consistently rewarding its shareholders. In comparison to its peers in the Healthcare sector, Pfizer lags behind only 10 companies that currently have a higher 12 Months dividend payout ratio.

Source for this article: Based on ’s official statement
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#Dividend, #NYSE, #payable, #PFE, #, #Major Pharmaceutical Preparations
Share this article:
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License